Alcon(ALC)
Focus: Alcon is a public ophthalmology-focused company headquartered in Fort Worth, TX, with a diversified portfolio spanning eye-care pharmaceuticals, surgical devices, and contact lens solutions. The company generates 43% of revenue from its flagship glaucoma treatment RHOPRESSA.
Profile data last refreshed 14h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Alcon
AI assessmentNot HiringNo open roles listed right now. Follow Alcon to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
1 in 5yr
SIMBRINZA
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$175M Part DStable
Peak7.6yr
Flagship product representing 43% of company revenue; drives profitability and funds R&D pipeline through 2034 exclusivity.
Help build intelligence for Alcon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.